drugset / Trial / NCT00540501
A Study to Evaluate Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Subjects
RandomizedSingle-groupOpen-labelTreatment
Summary
This study is a 4 period study to see if there is any interaction between Orally-Administered Oseltamivir and Intravenous Zanamivir in Healthy Thai Adult Subjects
Timeline
- Start
- 2007-10
- Primary completion
- 2007-10
- Completion
- 2007-10
Outcome
Outcome not reported
Stopped: “Contract agreement not reached”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oseltamivir | Small molecule | 150 mg | Oral |
| Subject | Zanamivir | Small molecule | 50 mg | Intravenous |
| Subject | Zanamivir | Small molecule | 600 mg | Intravenous |
Indications
No indication recorded.